Click here to view the Blue Cross Blue Shield BCBS Massachusetts Medical Policy Updates »…
Capital Blue Cross Medical Policy Updates – September 2022
Click here to view the Capital Blue Cross Medical Policy Updates »
September 2022 Capital Blue Cross Medical Policy Updates:
- Abecma (idecabtagene vicleucel) Medical Drug Program Summary
- Adakveo (crizanlizumab-tmca) Medical Drug Program Summary
- Aduhelm (Aducanumab-avwa) Medical Drug Program Summary
- Balloon Ostial Dilation for the Treatment of Chronic Rhinosinusitis
- Botulinum Toxin Preauthorization Request
- Breyanzi (Lisocabtagene Maraleucel) Medical Drug Program Summary
- Brineura (Cerliponase Alfa) Medical Drug Program Summary
- Cochlear Implant
- Cognitive Rehabilitation
- Computer Assisted Navigation for Orthopedic Procedures
- Cosela (trilaciclib) Medical Drug Program Summary
- Denosumab – Oncology Medical Drug Program Summary
- Diagnostic Testing and Risk Assessment for Alzheimer Disease (Biochemical and Genetic)
- Dry Needling of Myofascial Trigger Points
- Dynamic Posturography
- Enspryng (Satralizumabmwge) Medical Drug Program Summary
- Erectile Dysfunction
- Evenity Medical Drug Program Summary
- Evkeeza (evinacumab) Medical Drug Program Summary
- Eye Care
- Functional Endoscopic Sinus Surgery for Chronic Rhinosinusitis
- Gastric Electrical Stimulation
- General Approach to Genetic Testing
- Genetic Testing for Diagnosis and Management of Mental Health Conditions
- Genetic Testing for Hereditary Pancreatitis
- Genetic Testing for Macular Degeneration
- Genetic Testing For Marfan Syndrome, Thoracic Aortic Aneurysms And Dissections, And Related Disorders
- Genetic Testing Of Cadasil Syndrome
- Interventions for Progressive Scoliosis
- Intraoperative Neurophysiologic Monitoring
- Kymriah (Tisagenlecleucel) Medical Drug Program Summary
- Laparoscopic and Percutaneous Techniques for the Myolysis of Uterine Fibroids
- Light Therapies
- Manipulation Under Anesthesia
- Occipital Nerve Stimulation
- Ophthalmologic Techniques That Evaluate the Posterior Eye Segment for Glaucoma
- Opioid Antagonists Under Heavy Sedation Or General Anesthesia As A Technique Of Opioid Detoxification
- Optical Coherence Tomography OCT of the Anterior Eye Segment
- Orthopedic Applications of Platelet Rich Plasma
- Oxlumo™ (lumasiran)
- Postsurgical Home Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis
- Reblozyl (luspatercept-aamt) Medical Drug Program Summary
- Retinal Prosthesis
- Scenesse Medical Drug Program Summary
- Soliris (eculizumab) and Ultomiris (ravulizumab-cwvz) Medical Drug Program Summary
- Synagis (palivizumab) Medical Drug Program Summary
- Tecartus (Brexucabtagene Autoleucel) Medical Drug Program Summary
- Uplizna Medical Drug Program Summary
- Upper Limb Prostheses
- Whole Exome and Whole Genome Sequencing for Diagnosis of Genetic Disorders
- Wireless Capsule Endoscopy to Diagnose Disorders of the Small Bowel, Esophagus, and Colon
- Yescarta (Axicabtagene Ciloleucel) Medical Drug Program Summary
Click here to view the Capital Blue Cross Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.
Related Posts
